LEIDEN JEFFREY M (Executive Chairman) sold 72.6% of their position (63.78K shares) of VERTEX PHARMACEUTICALS INC / MA on the open market
Open‑market sale worth $28.65M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock
Shares
+63.78K
Price / share
$86.52
Trade value
$5.52M
% of position
Common Stock
Shares
−4.47K
Price / share
$440.40
Trade value
$1.97M
% of position
Common Stock
Shares
−1.32K
Price / share
$441.26
Trade value
$582.46K
% of position
Common Stock
Shares
−2.47K
Price / share
$443.21
Trade value
$1.09M
% of position
Common Stock
Shares
−4.35K
Price / share
$444.36
Trade value
$1.93M
% of position
Common Stock
Shares
−7.90K
Price / share
$445.56
Trade value
$3.52M
% of position
Common Stock
Shares
−1.15K
Price / share
$447.05
Trade value
$515K
% of position
Common Stock
Shares
−2.32K
Price / share
$448.78
Trade value
$1.04M
% of position
Common Stock
Shares
−5.88K
Price / share
$449.84
Trade value
$2.65M
% of position
Common Stock
Shares
−5.81K
Price / share
$451.20
Trade value
$2.62M
% of position
Common Stock
Shares
−15.68K
Price / share
$452.20
Trade value
$7.09M
% of position
Common Stock
Shares
−10.36K
Price / share
$453.34
Trade value
$4.70M
% of position
Common Stock
Shares
−2.07K
Price / share
$455.22
Trade value
$942.31K
% of position
Common Stock
Shares
+1.00
Price / share
$91.05
Trade value
$91.05
% of position
Net shares
+1.00
Net value
-$23.13M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/3/2025 | M · Option Exercise | +63.78K | $86.52 | $5.52M | 265.5% | 24.03K | 87.81K |
| Common Stock Direct | 12/3/2025 | S · Sale | −4.47K | $440.40 | $1.97M | 5.1% | 87.81K | 83.34K |
| Common Stock Direct | 12/3/2025 | S · Sale | −1.32K | $441.26 | $582.46K | 1.6% | 83.34K | 82.02K |
| Common Stock Direct | 12/3/2025 | S · Sale | −2.47K | $443.21 | $1.09M | 3.0% | 82.02K | 79.55K |
| Common Stock Direct | 12/3/2025 | S · Sale | −4.35K | $444.36 | $1.93M | 5.5% | 79.55K | 75.20K |
| Common Stock Direct | 12/3/2025 | S · Sale | −7.90K | $445.56 | $3.52M | 10.5% | 75.20K | 67.30K |
| Common Stock Direct | 12/3/2025 | S · Sale | −1.15K | $447.05 | $515K | 1.7% | 67.30K | 66.15K |
| Common Stock Direct | 12/3/2025 | S · Sale | −2.32K | $448.78 | $1.04M | 3.5% | 66.15K | 63.83K |
| Common Stock Direct | 12/3/2025 | S · Sale | −5.88K | $449.84 | $2.65M | 9.2% | 63.83K | 57.95K |
| Common Stock Direct | 12/3/2025 | S · Sale | −5.81K | $451.20 | $2.62M | 10.0% | 57.95K | 52.14K |
| Common Stock Direct | 12/3/2025 | S · Sale | −15.68K | $452.20 | $7.09M | 30.1% | 52.14K | 36.46K |
| Common Stock Direct | 12/3/2025 | S · Sale | −10.36K | $453.34 | $4.70M | 28.4% | 36.46K | 26.10K |
| Common Stock Direct | 12/3/2025 | S · Sale | −2.07K | $455.22 | $942.31K | 7.9% | 26.10K | 24.03K |
| Common Stock Direct | 12/4/2025 | M · Option Exercise | +1.00 | $91.05 | $91.05 | 0.0% | 24.03K | 24.03K |
| Total | +1.00 | -$23.13M | ||||||
Stock Option (Right to Buy)
Common Stock
63.78K shares
Shares
−63.78K
Strike price
86.52
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
1.00 shares
Shares
−1.00
Strike price
91.05
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock63.78K shares | 12/3/2025 | M · Option Exercise | −63.78K | 86.52 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock1.00 shares | 12/4/2025 | M · Option Exercise | −1.00 | 91.05 | — | 0.00 |
Common Stock
Indirect| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 440.00 | Indirect |
| Total | 440.00 | 440.00 indirect |